C. L. Kaul

3.9k total citations · 1 hit paper
112 papers, 3.3k citations indexed

About

C. L. Kaul is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, C. L. Kaul has authored 112 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Infectious Diseases and 16 papers in Physiology. Recurrent topics in C. L. Kaul's work include Tuberculosis Research and Epidemiology (12 papers), Receptor Mechanisms and Signaling (12 papers) and HIV/AIDS drug development and treatment (12 papers). C. L. Kaul is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Receptor Mechanisms and Signaling (12 papers) and HIV/AIDS drug development and treatment (12 papers). C. L. Kaul collaborates with scholars based in India, United Kingdom and Switzerland. C. L. Kaul's co-authors include Poduri Ramarao, K. K. Srinivasan, Bhoomi Viswanad, Ramesh Panchagnula, R. S. GREWAL, Meenakshisundaram Thiyagarajan, Shyam Sundar Sharma, Prashant S. Patole, Inderjit Singh and Kirandeep Kaur and has published in prestigious journals such as Nature, Journal of Geophysical Research Atmospheres and Journal of Medicinal Chemistry.

In The Last Decade

C. L. Kaul

101 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening

2005 1.6k citations K. K. Srinivasan, C. L. Kaul et al. profile →

Peers

C. L. Kaul

MB

EDM

PHYSI

SURGE

PHARM

B. Descomps France

Helen Wiseman United Kingdom

H David United States

Rubin Bressler United States

Giuseppe Rossoni Italy

G Curatola Italy

Reinhard Schinzel Germany

Harumi Okuyama Japan

Tonino Bucciarelli Italy

Félix Vargas Spain

B. Descomps France

C. L. Kaul

1.1k ×1.2

MB

546 ×0.6

EDM

483 ×0.7

PHYSI

660 ×1.8

SURGE

159 ×0.4

PHARM

Citations per year, relative to C. L. Kaul C. L. Kaul (= 1×) peers B. Descomps

Countries citing papers authored by C. L. Kaul

Since Specialization

Citations

This map shows the geographic impact of C. L. Kaul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. L. Kaul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. L. Kaul more than expected).

Fields of papers citing papers by C. L. Kaul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. L. Kaul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. L. Kaul. The network helps show where C. L. Kaul may publish in the future.

Co-authorship network of co-authors of C. L. Kaul

This figure shows the co-authorship network connecting the top 25 collaborators of C. L. Kaul. A scholar is included among the top collaborators of C. L. Kaul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. L. Kaul. C. L. Kaul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kaul, C. L.. (2006). Monarchical Display and the Politics of Empire: Princes of Wales and India 1870-1920s. Twentieth Century British History. 17(4). 464–488. 7 indexed citations

2.

Kumar, Arun, et al.. (2005). Effects of adenosine and adenosine A_2Areceptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy. Neurological Research. 27(1). 60–66. 27 indexed citations

3.

Singh, Inder Pal, et al.. (2004). Quality control of anti-tuberculosis fixed-dose combination formulations in the global market: an in vitro study.. PubMed. 8(9). 1081–8. 7 indexed citations

4.

Srinivasan, K. K., Prashant S. Patole, C. L. Kaul, & Poduri Ramarao. (2004). Reversal of glucose intolerance by by pioglitazone in high fatdiet-fed rats. Methods and Findings in Experimental and Clinical Pharmacology. 26(5). 327–327. 165 indexed citations

5.

Kaul, C. L., et al.. (2003). Pharmacokinetic evaluation of an azithromycin controlled release dosage form in healthy human volunteers: a single dose study. International Journal of Pharmaceutics. 270(1-2). 1–8. 9 indexed citations

6.

Singh, Inderjit, et al.. (2002). Bioequivalence assessment of rifampicin, isoniazid and pyrazinamide in a fixed dose combination of rifampicin, isoniazid, pyrazinamide and ethambutol vs. separate formulations. International Journal of Clinical Pharmacology and Therapeutics. 40(10). 474–481. 20 indexed citations

7.

Thiyagarajan, Meenakshisundaram, C. L. Kaul, & Poduri Ramarao. (2002). Enhancement of α-adrenoceptor-mediated responses in prostate of testosterone-treated rat. European Journal of Pharmacology. 453(2-3). 335–344. 19 indexed citations

8.

Panchagnula, Ramesh, Shruti Agrawal, & C. L. Kaul. (2001). Fixed Dose Combinations In The Treatment Of Tuberculosis. Indian Journal of Pharmaceutical Sciences. 63(1). 1. 3 indexed citations

9.

Kaul, C. L., et al.. (2001). The role of aldose reductase inhibitors in diabetic complications:Recent trends. Methods and Findings in Experimental and Clinical Pharmacology. 23(8). 465–465. 28 indexed citations

10.

Joshi, U., K. S. Baliyan, S. Ganesh, et al.. (2000). Coordinated TeV gamma-ray and optical polarization study of BL Lac object Mkn 501. Bulletin of the Astronomical Society of India. 28. 409–411. 2 indexed citations

11.

Jones, Robert B., et al.. (1997). Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats. British Journal of Pharmacology. 120(6). 1135–1143. 19 indexed citations

12.

Bhopale, Kamlesh K., et al.. (1993). Comparative pharmacokinetics and amoebicidal activity of metronidazole and satranidazole in the golden hamster, Mesocricetus auratus. Journal of Antimicrobial Chemotherapy. 32(3). 483–489. 6 indexed citations

13.

Kaul, C. L., et al.. (1981). Causes of Forbush Decreases. ICRC. 4. 21. 3 indexed citations

14.

Kaul, C. L., et al.. (1980). Seasonal incidence of aphid, Dactynotus carthami and coccinellids in correlation to weather conditions.. Indian journal of plant protection. 8(2). 117–121. 2 indexed citations

15.

Kaul, C. L., et al.. (1979). Forbush Decreases, Flares and Recurrent Streams. International Cosmic Ray Conference. 3. 423.

16.

Kaul, C. L., et al.. (1977). Recurrent Forbush Decreases and Relationship between Active Regions and M-Regions. ICRC. 3. 323. 1 indexed citations

17.

Razdan, H., et al.. (1975). Cosmic Ray, Modulation by Corotating Solar Streams in Presence of Flare Plasma Clouds. International Cosmic Ray Conference. 3. 1058. 1 indexed citations

18.

Kaul, C. L.. (1971). Investigations into Causes of Sterility:III. Gametocide-induced male-sterile Vicia faba L. CYTOLOGIA. 36(2). 219–228. 2 indexed citations

19.

Kaul, C. L.. (1970). Investigations into Causes of Sterility:II. Tabernaemontana cornaria Willd. CYTOLOGIA. 35(4). 570–576. 1 indexed citations

20.

Kaul, C. L. & J J Lewis. (1963). THE EFFECTS OF RESERPINE AND SOME RELATED COMPOUNDS UPON THE LEVELS OF ADENINE NUCLEOTIDES, CREATINE PHOSPHATE AND INORGANIC PHOSPHATE IN THE RAT BRAIN IN VIVO. Journal of Pharmacology and Experimental Therapeutics. 140(1). 111–116. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact